Skip to content

Clinical trials

Observational Diabetic Retinopathy trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Observational Country / region: China Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20151
20172
20187
20191
20202
20211
20222
20243
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11
Completed8
Not yet recruiting4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhongshan Ophthalmic Center, Sun Yat-sen University5
Bayer2
Shanghai Eye Disease Prevention and Treatment Center2
Guangdong Provincial People's Hospital1
Harbin Medical University1
Li Xiaorong1
Mingzhe Cao1
Ningbo Eye Hospital1
Peking University Third Hospital1
Qilu Hospital of Shandong University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy26
Diabetes Mellitus4
Diabetes Mellitus, Type 23
Retinal Diseases3
Retinal Vein Occlusion3
Glaucoma, Neovascular2
Macular Degeneration2
Behcet Syndrome1
Central Serous Chorioretinopathy1
Choroid Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.